A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for the treatment of a chronic lung condition, the drugmaker said on Friday.

Fetal exposure to inflammation has long been identified as a risk factor for a range of harmful conditions, but new research ...

Visible on chest CT scans, post-COVID-19 residual lung abnormalities, which affect up to 50% of patients who have had an ...